# Evaluation With CT Scan of Possible Changes in Airways After Treatment With Daxas® in Severe Chronic Obstructive Pulmonary Disease Patients

> **NCT01480661** · PHASE4 · COMPLETED · sponsor: **FLUIDDA nv** · enrollment: 41 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Roflumilast
- **DRUG:** Placebo of Roflumilast
- **RADIATION:** Functional Respiratory Imaging

## Key facts

- **NCT ID:** NCT01480661
- **Lead sponsor:** FLUIDDA nv
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2013-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01480661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01480661, "Evaluation With CT Scan of Possible Changes in Airways After Treatment With Daxas® in Severe Chronic Obstructive Pulmonary Disease Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01480661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*